Bexion Pharmaceuticals
KY - CovingtonPharmaceutical
Focus: Bexion Pharmaceuticals is a niche biotech company focused on synthetically produced human lysosomal proteins, with a specialized pipeline targeting neurology and oncology indications. Founded in 1999 and publicly traded, the company operates at a modest scale with early-stage clinical programs.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Bexion Pharmaceuticals
AI assessmentNot HiringNo open roles listed right now. Follow Bexion Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
6 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
BXQ-350 - Part 1 Dose Escalation: Safety and Tolerance
Diffuse Intrinsic Pontine GliomaClinical Trials (1)
NCT04771897A Study of BXQ-350 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) or Diffuse Midline Glioma (DMG)
Phase 1Help build intelligence for Bexion Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.